Evidence map›Paper›PMID 35672430›Full record

ArticleScientific reports2022

Genomic insights of high-risk clones of ESBL-producing Escherichia coli isolated from community infections and commercial meat in southern Brazil.

João Gabriel Material Soncini, Louise Cerdeira, Elder Sano, Vanessa Lumi Koga, Ariane Tiemy Tizura, Zuleica Naomi Tano, Gerson Nakazato, Renata Katsuko Takayama Kobayashi, Caio Augusto Martins Aires, Nilton Lincopan and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Fluoroquinolone resistantFrontiers in microbiology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Extended-spectrumFrontiers in microbiology · 2025
    Article
  12. Article
  13. Molecular Analysis ofMicroorganisms · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Sporadic cloneFrontiers in cellular and infection microbiology · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

João Gabriel Material SonciniLaboratory of Clinical Microbiology, Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, State University of Londrina, Londrina, Brazil.
Louise CerdeiraDepartment of Infectious Diseases, Central Clinical School, Monash University, Melbourne, Australia.
Elder SanoDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Vanessa Lumi KogaLaboratory of Clinical Microbiology, Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, State University of Londrina, Londrina, Brazil.
Ariane Tiemy TizuraLaboratory of Clinical Microbiology, Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, State University of Londrina, Londrina, Brazil.
Zuleica Naomi TanoLaboratory of Clinical Microbiology, Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, State University of Londrina, Londrina, Brazil.
Gerson NakazatoDepartament of Microbiology, Biological Science Center, State University of Londrina, Londrina, Brazil.
Renata Katsuko Takayama KobayashiDepartament of Microbiology, Biological Science Center, State University of Londrina, Londrina, Brazil.
Caio Augusto Martins AiresDepartment of Health Science, Health and Biological Science Center, Federal Rural University of Semi-Arid Region, Mossoró, Brazil.
Nilton LincopanDepartment of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Eliana Carolina VesperoLaboratory of Clinical Microbiology, Department of Pathology, Clinical and Toxicological Analysis, Health Sciences Center, State University of Londrina, Londrina, Brazil. eliana.vespero@gmail.com.
Universidade Estadual de Londrina · BRUniversidade de São Paulo · BRMonash University · AUUniversidade Federal Rural do Semi-Árido · BR

Funding

Bill & Melinda Gates Foundation OPP1193112
6 · The paper itself

Abstract

During a microbiological and genomic surveillance study conducted to investigate the molecular epidemiology of extended-spectrum β-lactamase (ESBL)-producing Escherichia coli from community-acquired urinary tract infections (UTI) and commercial meat samples, in a Brazilian city with a high occurrence of infections by ESBL-producing bacteria, we have identified the presence of CTX-M (-2, -14, -15, -24, -27 and -55)-producing E. coli of international clones ST38, ST117, ST131 and ST354. The ST131 was more prevalent in human samples, and worryingly the high-risk ST131-C1-M27 was identified in human infections for the first time. We also detected CTX-M-55-producing E. coli ST117 from meat samples (i.e., chicken and pork) and human infections. Moreover, the clinically relevant CTX-M-24-positive E. coli ST354 clone was detected for the first time in human samples. In summary, our results highlight a potential of commercialized meat as a reservoir of high-priority E. coli lineages in the community, whereas the identification of E. coli ST131-C1-M27 indicates that novel pandemic clones have emerged in Brazil, constituting a public health issue.

Indexed as

Community-Acquired InfectionsEscherichia coli InfectionsAnti-Bacterial Agentsbeta-LactamasesBrazilClone CellsEscherichia coliGenomicsHumansMeatAnti-Bacterial Agentsbeta-Lactamases

Identifiers

PMID35672430
PMCPMC9174282
OpenAlexW4281675344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.